BALKRISIND Q2 FY27 Results & Earnings Analysis
Sentiment: Neutral (Confidence: medium)
Earnings Summary
Balkrishna Industries delivered strong Q2 FY27 revenue growth of 49% YoY to INR3,450 crores (H1 up 35% YoY to INR6,859 crores) driven by volume growth and low base effect. However, EBITDA margin contracted to 18.24% in Q2 vs 19.42% in H1 due to raw material inflation (~17% jump in RM cost) and elevated freight costs (6.5% of sales), with only partial 2-3% price hikes passed through. Management expects cost headwinds to continue for next few quarters. Strategic Pirelli tie-up for premium PCR tires and Vision 2030 targets (5% market share, 20% turnover from on-road by 2030) provide long-term growth levers. Capex of INR1,850 crores spent in H1 with remaining to be spent over next two years. Net debt at INR2,887 crores. Board declared second interim dividend of INR4/share. Key investor concerns: margin recovery visibility, demand sustainability in Europe, and lack of explicit revenue/margin guidance.
Management Tone
- Prepared Remarks: Good — Management highlighted strong volume growth, positive momentum in India, stable US sales, and strategic Pirelli tie-up for premium PCR production. Acknowledged cost headwinds but maintained a forward-looking positive stance.
- Q&A Session: Neutral — Analysts pressed on margin pressure, price hikes, and demand recovery. Management was evasive on quantifying commodity inflation impact and future margin trajectory, repeatedly citing 'forward-looking statements' and refusing to comment on specific numbers.
Revenue Growth Drivers
- Volume growth from uptick in end markets and segments, including India outperformance and stable Americas
- Low base effect from US tariff situation in prior year Q2
- Price hikes of 2-3% mainly in Indian market to partially offset cost inflation
Growth vs Margin Focus
Management emphasized judicious mix of price and volume to balance growth and profitability, stating 'we use a judicious mix of price and volume play to continue to balance out growth as well as profitability. It will be a tactical play between the two.' Long-term EBITDA margin endeavor is 20-25%.
About Balkrishna Industries Ltd.
Balkrishna Industries Ltd. (BALKRISIND) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.